Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Financial Statements
- Click here to download Abiomed Inc.'s Income Statement
- Click here to download Abiomed Inc.'s Balance Sheet
- Click here to download Abiomed Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Minogue
Key Statistics
- Stock Price: $310.7
- Dividend Yield: 0%
- Market Capitalization: $14,214,709,260
- Shares Outstanding: 45,516,200
- Number of Employees: 1,725
- Trailing 12-Month EPS: $2.91
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2022-04-28
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $310.7
- 52-week high: $379.3
- 52-week low: $261.27
- 200-day moving average: $332.48
- 50-day moving average: $301.58
Performance
- 1-Month Price Return: 12.6%
- 3-Month Price Return: -4.2%
- 6-Month Price Return: -12.9%
- 1-Year Price Return: -3.8%
- 2-Year Price Return: 102.8%
- 5-Year Price Return: 164.8%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast